GlaxoSmithKline

GSK is one of the world’s leading research-based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer

Meningitis Now corporate partners GlaxoSmithKlein

Pictured: A statue of meningitis survivor Liam Doyle, created as part of our 30th anniversary exhibition at the RHS Chelsea Flower Show in 2016. This is now located permanently at GSK's plant in Siena, Italy, where the meningitis vaccine Bexsero is manufactured.

As a global healthcare company, GSK has three businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. It is committed to widening access to its products so more people can benefit, no matter where they live in the world or what they can afford to pay.

GSK manufactures a number of vaccines worldwide, some of which are on the UK national immunisation schedule.  

Over the past decade, GSK have donated over £170,000 towards a number of Meningitis Now awareness projects and support services, helping to make a meaningful difference to our fight against this devastating disease.

Meningitis Now has utilised donations from GSK to register nearly 500 nurseries and childcare providers across the UK to receive our Meningitis Awareness Recognition Mark (MARM). Funds from GSK have also helped us to support more than 100 young people through our Believe and Achieve programme. 

This year, a donation from GSK have helped to secure the creation of thousands of Meningitis Now signs and symptoms cards. These cards are a central feature of our awareness raising activities and are distributed to schools, businesses, healthcare organisations and at our events. 

Knowing the signs and symptoms of meningitis and septicaemia and what action to take if you suspect the disease really can save lives. During our 33-year history, we have distributed more than 22 million cards. The latest donation from GSK ensures that we will reach even more people with this potentially critical information.

Mark Jefferies, Senior Partnerships Fundraiser, said, “We are so pleased to be able to use this latest donation from GSK towards the printing costs of our signs and symptoms cards. Raising awareness of this disease has remained a core objective of Meningitis Now throughout our existence. We take enormous pride in the way that partners such as GSK continue to support our work.”

Visit GSK online.